February 2, 2009 - The University Hospital of Leuven delivered treatment using RapidArc radiotherapy technology from Varian Medical Systems, on a74-year-old prostate cancer patient has become the first person in Belgium to be treated using a new, faster form of radiotherapy that extends more advanced care to more patients.

The patient, a retired military aircraft engineer from Kortenberg near Leuven, said he was pleased to be the country’s first to receive this advanced form of image-guided intensity modulated radiotherapy (IMRT). By coincidence, his older brother was also treated for prostate cancer at the hospital two years ago, receiving a successful course of conventional IMRT.

"This patient is now feeling very well and he is very proud of being number one in Belgium," says Karin Haustermans, M.D., head of the Department of Oncology. "We are identifying patients for whom RapidArc is a beneficial treatment and we have been very pleased with the early results. Not everyone will be treated in this way but it appears to have major advantages in speed and precision for many of our prostate cancer patients."

Frank Van den Heuvel, director of physics, believes RapidArc will enable the hospital to bring down standard treatment slots from 12 minutes to ten minutes, enabling six patients to be treated per hour rather than five. "This is an entirely new technique for us so early treatments will inevitably take a
little longer but once it becomes a part of our routine I believe we can achieve these targets," he said.

The University Hospital of Leuven treats up to 200 patients per day on five Varian Clinac linear accelerators. The hospital was one of the earliest in Europe to introduce IMRT treatments and the technique is now used routinely for prostate, head & neck, oesophagus and rectal cancer treatments.
As the hospital becomes more familiar with the technique, RapidArc image-guided IMRT treatments will gradually be introduced for indications other than prostate cancer.

For more information: www.varian.com


Related Content

News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Proton Therapy

June 14, 2024 — Atlantic Health System, an integrated health care system setting standards for quality health care in ...

Time June 14, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 21, 2024 — RaySearch Laboratories AB announced that the oncology information system RayCare* 2024A has been ...

Time May 21, 2024
arrow
News | Artificial Intelligence

May 14, 2024 — Elekta announced the launch of its latest linear accelerator (linac), Evo*, a CT-Linac with new high ...

Time May 14, 2024
arrow
News | Proton Therapy

January 26, 2024 — P-Cure continues its quest to successfully usher in a new era of clinical treatment with proton ...

Time January 26, 2024
arrow
News | Linear Accelerators

October 25, 2023 — A new order for several Elekta Harmony linear accelerators (linacs) in Ukraine will complement the ...

Time October 25, 2023
arrow
News | Radiation Therapy

October 5, 2023 — A new study, led by radiation oncology physicists at Miami Cancer Institute, part of Baptist Health ...

Time October 05, 2023
arrow
News | Oncology Information Management Systems (OIMS)

May 24, 2023 — RaySearch Laboratories AB announced that the oncology information system RayCare* (* subject to ...

Time May 24, 2023
arrow
News | Proton Therapy

April 3, 2023 — P-Cure announced clearance of its Adaptive Proton Therapy Solution by the FDA for sales in the USA. P ...

Time April 03, 2023
arrow
News | Radiation Therapy

February 28, 2023 — Elekta announced that Comprehensive Motion Management (CMM) with True Tracking and automatic gating ...

Time February 28, 2023
arrow
Subscribe Now